Tjeerd Barf

Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile

Tjeerd Barf, Todd Covey, Raquel Izumi et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 357 citations · Full text

Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635

Håkan Hall, Camilla Lundkvist, Christer Halldin et al. · Brain Research · 1997 · 280 citations

Neuroanatomy, 5-Ht1a Receptors, Neurophysiological Biomarkers +10

Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1

Tjeerd Barf, Jerk Vallgårda, Rikard Emond et al. · Journal of Medicinal Chemistry · 2002 · 211 citations · Full text

Pharmaceutical Science, Selective Inhibitors, Pharmacotherapy +20

N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors

Tjeerd Barf, Fredrik Lehmann, Kristin Hammer et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 107 citations · Full text

Lipid Synthesis, Biochemistry, Medicine +6

Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methl-11C]WAY-100635, in monkey and human plasma by HPLC: Comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET

Safiye Osman, Camilla Lundkvist, Victor W. Pike et al. · Nuclear Medicine and Biology · 1996 · 93 citations

Biochemistry, Radioactive Metabolites, Medicine +8